Risk Factors | B | S.E. | Wald | df | Sig. | Odd ratio/Exp (B) | 95% C.I. for EXP(B) | ||
---|---|---|---|---|---|---|---|---|---|
Lower | Upper | ||||||||
ICU length of stay | SOFA score | 0.251 | 0.033 | 56.631 | 1 | < 0.001 | 1.285 | 1.204 | 1.372 |
APACHE II score | 0.082 | 0.015 | 29.625 | 1 | < 0.001 | 1.085 | 1.054 | 1.118 | |
GCS score | − 0.156 | 0.033 | 22.857 | 1 | < 0.001 | 0.855 | 0.802 | 0.912 | |
Body temperature (°C) | − 0.136 | 0.06 | 5.056 | 1 | 0.025 | 0.873 | 0.775 | 0.983 | |
MAP (mmHg) | − 0.014 | 0.004 | 9.600 | 1 | 0.002 | 0.987 | 0.978 | 0.995 | |
Platelet count ×104/mm3 | − 0.023 | 0.009 | 6.552 | 1 | 0.010 | 0.977 | 0.96 | 0.995 | |
Creatinine (mg/dl) | 0.174 | 0.060 | 8.552 | 1 | 0.003 | 1.190 | 1.059 | 1.338 | |
Na | 0.041 | 0.014 | 8.315 | 1 | 0.004 | 1.042 | 1.013 | 1.072 | |
pH | − 3.441 | 0.869 | 15.671 | 1 | < 0.001 | 0.032 | 0.006 | 0.176 | |
PaO2/FiO2 ratio | − 0.003 | 0.001 | 14.239 | 1 | < 0.001 | 0.997 | 0.995 | 0.999 | |
Albumin use | 1.325 | 0.284 | 21.838 | 1 | < 0.001 | 3.763 | 2.158 | 6.559 | |
Application of vasopressor agents | 1.270 | 0.197 | 41.592 | 1 | < 0.001 | 3.561 | 2.421 | 5.239 | |
Steroid use | 1.045 | 0.273 | 14.620 | 1 | < 0.001 | 2.845 | 1.665 | 4.861 | |
Need for MV in the first 24 h | 1.232 | 0.200 | 38.106 | 1 | < 0.001 | 3.427 | 2.318 | 5.068 | |
Hospital Length of Stay | SOFA score | 0.173 | 0.030 | 32.926 | 1 | < 0.001 | 1.188 | 1.120 | 1.261 |
APACHE II score | 0.073 | 0.015 | 24.687 | 1 | < 0.001 | 1.076 | 1.045 | 1.108 | |
GCS score | − 0.095 | 0.030 | 10.139 | 1 | 0.001 | 0.909 | 0.858 | 0.964 | |
Body temperature (°C ) | − 0.240 | 0.067 | 12.651 | 1 | < 0.001 | 0.787 | 0.689 | 0.898 | |
MAP (mmHg) | − 0.020 | 0.005 | 20.239 | 1 | < 0.001 | 0.980 | 0.971 | 0.988 | |
HCT (%) | − 0.043 | 0.014 | 9.482 | 1 | 0.002 | 0.958 | 0.933 | 0.985 | |
Creatinine (mg/dl) | 0.143 | 0.057 | 6.228 | 1 | 0.013 | 1.154 | 1.031 | 1.291 | |
pH | − 2.241 | 0.803 | 7.793 | 1 | 0.005 | 0.106 | 0.022 | 0.513 | |
C-reactive protein (mg/dl) | 0.029 | 0.008 | 13.132 | 1 | < 0.001 | 1.030 | 1.014 | 1.046 | |
Albumin use | 1.232 | 0.276 | 19.961 | 1 | < 0.001 | 3.429 | 1.997 | 5.887 | |
Application of vasopressor agents | 1.496 | 0.200 | 55.713 | 1 | < 0.001 | 4.466 | 3.015 | 6.615 | |
Steroid use | 1.034 | 0.271 | 14.613 | 1 | < 0.001 | 2.813 | 1.655 | 4.780 | |
Need for MV in the first 24 hours | 1.600 | 0.206 | 60.397 | 1 | < 0.001 | 4.955 | 3.309 | 7.418 |